Lonsurf - RII Lonsurf (TAS-102) with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer. A randomized phase II study
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Primary objective: • Progression-free survival (PFS) Primary end-point: • Progression-free survival (PFS)
创建时间：
2017-04-15
